The Recall Desk
HighFDA (Devices)·Z-1095-2026·Announced 2026-01-21

Coagulation reagent recalled over potential for microbial contamination

Instrumentation Laboratory is recalling 7,720 units of a coagulation reagent used for evaluating the intrinsic pathway and monitoring heparin therapy over potential microbial contamination.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Scored 3 under the risk-of-harm criterion: the record cites potential microbial contamination of a laboratory reagent, and no injuries are reported.

Plain-English summary

The product, described in the record as used for the evaluation of the intrinsic coagulation pathway, the APTT substitution test and the monitoring of heparin therapy, is being recalled by Instrumentation Laboratory.

The reason given in the enforcement record is the potential for microbial contamination.

The record lists 7,720 units, part number 0020006800, UDI-DI 08426950078920, from lot N1136730 with an expiration date of 12/31/2025. Distribution was worldwide, including nationwide in the United States across California, Florida, Illinois, Minnesota, Mississippi, Nebraska, Ohio, Texas and Wisconsin. The FDA has classified the action as Class II.

The enforcement record reports no injuries. Laboratories should quarantine the affected lot and follow the firm's instructions.

The recalled product

Product
The product is used for the evaluation of the intrinsic coagulation pathway, APTT substitution test and the monitoring of heparin therapy.
Affected units
7,720

Distribution

Distributed nationwide across the United States.

The notice also names 9 states specifically: